Anticholinergic Burden in Children, Adults and Older Adults in Slovenia: A Nationwide Database Study.

Scientific Reports
Nanca Cebron LipovecMitja Kos

Abstract

Anticholinergic burden has been widely studied in specific patient populations with specific conditions. However, the prevalence in the general population is poorly understood. This retrospective cross-sectional study was a nationwide database analysis of outpatient prescriptions of anticholinergic medications. The study was based on Slovenian health claims data of all outpatient prescriptions in 2018. Anticholinergic burden was evaluated using the Anticholinergic Cognitive Burden scale. Three age groups were analysed: children (≤18 years), adults (19-64 years) and older adults (≥65 years). Anticholinergic medications were prescribed to 29.8% of the participants; 7.6% were exposed to a clinically significant anticholinergic burden. The proportion of patients exposed to anticholinergic burden was highest in older adults (43.2%), followed by adults (25.8%) and children (20.7%). The most frequently prescribed medications with the highest anticholinergic activity were antipsychotics and medications for urinary diseases (42.8% and 40.2%, respectively). Medications with second highest activity were mostly antiepileptics (87.3%). Medications with possible anticholinergic activity included diverse therapeutic groups. Anticholinergic bu...Continue Reading

References

Jul 1, 2010·The Annals of Pharmacotherapy·Irene Seunghyun Hong, Jeffrey R Bishop
Mar 27, 2013·European Journal of Clinical Pharmacology·Carlos E DuránRobert H Vander Stichele
Sep 14, 2013·Journal of the American Pharmacists Association : JAPhA·Teri WestRuth Emptage
Feb 19, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Sarah L Anderson, Joseph P Vande Griend
Mar 22, 2014·International Journal of Epidemiology·Zachary SteelDerrick Silove
Oct 6, 2014·Journal of the American Medical Directors Association·Francesco LandiAntonio Cherubini
Jan 27, 2015·JAMA Internal Medicine·Shelly L GrayEric B Larson
Aug 1, 2015·The Annals of Pharmacotherapy·Zachary A MarcumUNKNOWN Health ABC Study, USA
Oct 9, 2015·Journal of the American Geriatrics Society·UNKNOWN By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel
Mar 12, 2016·Expert Opinion on Drug Safety·Prasad S NishtalaSarah N Hilmer
Apr 3, 2016·Drugs & Aging·Mohammed Saji Salahudeen, Prasad S Nishtala
Apr 22, 2017·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Kate MaddenRobert C Tasker
May 30, 2017·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Nika Marđetko, Mitja Kos
Jul 19, 2017·Research in Social & Administrative Pharmacy : RSAP·Janja JazbarMitja Kos
Apr 27, 2018·BMJ : British Medical Journal·Kathryn RichardsonGeorge M Savva
Oct 5, 2018·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Kate MaddenRobert C Tasker
Jun 4, 2019·Archives of Gerontology and Geriatrics·Greta Lozano-OrtegaDaniel B Ng
Jun 25, 2019·JAMA Internal Medicine·Carol A C CouplandJulia Hippisley-Cox

❮ Previous
Next ❯

Software Mentioned

SPSS Statistics

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here